This enhanced effect is attributed to IronQ-induced secretion of hepatocyte growth factor (HGF) by MSCs, which activates the HGF/c-Met signaling pathway, improving MSCs' ability to treat acute kidney injury (AKI) [[36], [37], [38]]. This evidence concerns the gene MET and acute kidney injury.